Intravenous Administration of Self-complementary AAV9 Enables Transgene Delivery to Adult Motor Neurons
Top Cited Papers
Open Access
- 1 July 2009
- journal article
- research article
- Published by Elsevier in Molecular Therapy
- Vol. 17 (7) , 1187-1196
- https://doi.org/10.1038/mt.2009.71
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosisNature Neuroscience, 2008
- Neonatal Intraperitoneal or Intravenous Injections of Recombinant Adeno-Associated Virus Type 8 Transduce Dorsal Root Ganglia and Lower Motor NeuronsHuman Gene Therapy, 2008
- Intraparenchymal spinal cord delivery of adeno-associated virus IGF-1 is protective in the SOD1G93A model of ALSBrain Research, 2007
- The 37/67-Kilodalton Laminin Receptor Is a Receptor for Adeno-Associated Virus Serotypes 8, 2, 3, and 9Journal of Virology, 2006
- Efficacy and safety of adeno‐associated viral vectors based on serotype 8 and 9 vs. lentiviral vectors for hemophilia B gene therapyJournal of Thrombosis and Haemostasis, 2006
- Molecular biology of amyotrophic lateral sclerosis: insights from geneticsNature Reviews Neuroscience, 2006
- An ~140-kb deletion associated with feline spinal muscular atrophy implies an essentialLIX1function for motor neuron survivalGenome Research, 2006
- Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8Molecular Therapy, 2006
- AAV transcytosis through barrier epithelia and endotheliumMolecular Therapy, 2006
- Studies on the permeability of the blood-retinal barrier. I. On the existence, development, and site of a blood-retinal barrier.British Journal of Ophthalmology, 1966